MACK - Merrimack Pharmaceuticals GAAP EPS of -$0.04 August, 04 2022 05:12 PM Merrimack Pharmaceuticals Inc. Merrimack Pharmaceuticals press release ( NASDAQ: MACK ): Q2 GAAP EPS of -$0.04. As of June 30, 2022, Merrimack had cash and cash equivalents of $13.4 million, compared to $14.2 million as of December 31, 2021. For further details see: Merrimack Pharmaceuticals GAAP EPS of -$0.04